Ibere Pharmaceuticals Cl A (IBER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 458 | 175 | N/A |
| TOTAL | $693 | $175 | $N/A |
| Non-Current Assets | |||
| Investments And Advances | 138,017 | 0 | 0 |
| Other Non-Current Assets | 0 | 501 | 0 |
| TOTAL | $138,017 | $501 | $N/A |
| Total Assets | $138,710 | $676 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 0 | 169 | N/A |
| Accrued Expenses | 372 | 488 | N/A |
| TOTAL | $372 | $657 | $N/A |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 149,184 | 0 | 0 |
| TOTAL | $149,184 | $N/A | $N/A |
| Total Liabilities | $149,556 | $657 | $N/A |
| Shareholders' Equity | |||
| Shares Outstanding, K | 17,250 | N/A | N/A |
| Retained earnings | -10,846 | -6 | N/A |
| TOTAL | $-10,846 | $19 | $N/A |
| Total Liabilities And Equity | $138,710 | $676 | $0 |